Aravive, Inc.
ARAV · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | -0.01 | -0.02 |
| FCF Yield | -98.10% | -14.06% | -11.72% | -17.15% |
| EV / EBITDA | -0.10 | -2.63 | 7.67 | -1.80 |
| Quality | ||||
| ROIC | -165.29% | -92.13% | 100.33% | -59.75% |
| Gross Margin | -216.76% | -746.94% | -967.40% | -1,117.98% |
| Cash Conversion Ratio | -0.46 | -0.98 | 0.36 | 0.49 |
| Growth | ||||
| Revenue 3-Year CAGR | -16.79% | -1.87% | 17.09% | 17.14% |
| Free Cash Flow Growth | 44.45% | 0.54% | -24.60% | 24.75% |
| Safety | ||||
| Net Debt / EBITDA | 0.16 | 0.37 | -2.09 | 2.39 |
| Interest Coverage | 0.00 | 0.00 | 0.46 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -9.35 |
| Cash Conversion Cycle | -55.91 | -32.47 | -55.39 | -48.38 |